Publication | Closed Access

Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1–7/Mas receptor cascade

Metabolic SyndromeMolecular PharmacologyYoung Db/db MiceMolecular PhysiologyCardiomyopathyCardiovascular DiseaseMedicineVascular PharmacologyDiabetesPhysiologyCardiovascular PharmacologyReceptor CascadeVascular BiologyDiabetic CardiomyopathyPharmacologyHealth Sciences